Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603

Abstract

Background

Magnetic resonance enteroclysis (MRE) has been widely applied to diagnose Crohn’s disease (CD). Magnetic resonance (MR) at 3.0 T improves signal-to-noise ratio (SNR), shortens image acquisition time, and shows more advantages.

Objective

This study aimed to retrospectively analyze the diagnostic value of 3.0 T MR imaging for active CD.

Methods

48 CD patients hospitalized in our hospital from January 2021 to December 2022 were selected as the study subjects. These 48 CD patients underwent both double-balloon enteroscopy and 3.0 T MRE. All patients' arterial phase signal, venous phase signal, bowel wall, and bowel lumen of MRE were observed to identify whether they suffered from active CD. Based on the results of enteroscopy, the number of true positives, true negatives, false negatives, and false positives diagnosed by MRE were screened; next, the diagnostic accuracy, sensitivity, and specificity of MRE in assessing active CD were calculated.

Results

Of the 48 patients, 39 were diagnosed with small bowel CD by MRE, which was not significantly different from the results of enteroscopy (>0.05). According to MRE diagnostic results, the arterial phase predominantly presented high signal intensity, and the venous phase mainly presented low signal intensity or isointensity. Small bowel CD lesions were primarily characterized by bowel wall thickening, rare pneumatosis enhancement of the bowel wall, bowel lumen pneumatosis or dilatation, and rare strictures. Besides, MRE presented an accuracy of 93.75%, sensitivity of 97.37%, and specificity of 80.00% in diagnosing CD.

Conclusion

3.0 T MR imaging has diagnostic value for active CD and shows certain clinical application value.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056267653231129104404
2024-01-01
2025-06-18
The full text of this item is not currently available.

References

  1. KhannaS. RaffalsL.E. The microbiome in Crohn’s Disease.Gastroenterol. Clin. North Am.201746348149210.1016/j.gtc.2017.05.00428838410
    [Google Scholar]
  2. PetagnaL. AntonelliA. GaniniC. BellatoV. CampanelliM. DiviziaA. EfratiC. FranceschilliM. GuidaA.M. IngallinellaS. MontagneseF. SensiB. SiragusaL. SicaG.S. Pathophysiology of Crohn’s disease inflammation and recurrence.Biol. Direct20201512310.1186/s13062‑020‑00280‑533160400
    [Google Scholar]
  3. ParigiT.L. D’AmicoF. DaneseS. Upadacitinib for crohn’s disease and ulcerative colitis treatment: Hitting the selective JAKpot.Gastroenterology202116051472147410.1053/j.gastro.2020.04.03432311362
    [Google Scholar]
  4. AtreyaR. SiegmundB. Location is important: Differentiation between ileal and colonic Crohn’s disease.Nat. Rev. Gastroenterol. Hepatol.202118854455810.1038/s41575‑021‑00424‑633712743
    [Google Scholar]
  5. WhiteJ.R. JairathV. MoranG.W. Evolution of treatment targets in Crohn's disease.Best Pract Res Clin Gastroenterol201938-3910159910.1016/j.bpg.2019.02.001
    [Google Scholar]
  6. FongS.C.M. IrvingP.M. Distinct management issues with Crohnʼs disease of the small intestine.Curr. Opin. Gastroenterol.2015312929710.1097/MOG.000000000000014925594888
    [Google Scholar]
  7. AjajW. LauensteinT.C. LanghorstJ. KuehleC. GoyenM. ZoepfT. RuehmS.G. GerkenG. DebatinJ.F. GoehdeS.C. Small bowel hydro‐MR imaging for optimized ileocecal distension in Crohn’s disease: Should an additional rectal enema filling be performed?J. Magn. Reson. Imaging20052219210010.1002/jmri.2034215971189
    [Google Scholar]
  8. GuimarãesL.S. GreerM.L.C. DillmanJ.R. FletcherJ.G. Magnetic resonance in Crohn’s Disease.Magn. Reson. Imaging Clin. N. Am.2020281314410.1016/j.mric.2019.08.00331753235
    [Google Scholar]
  9. FiorinoG. BonifacioC. Peyrin-BirouletL. MinutiF. RepiciA. SpinelliA. FriesW. BalzariniL. MontorsiM. MalesciA. DaneseS. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohnʼs disease.Inflamm. Bowel Dis.20111751073108010.1002/ibd.2153321484958
    [Google Scholar]
  10. HorsthuisK. BipatS. BenninkR.J. StokerJ. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: Meta-analysis of prospective studies.Radiology20082471647910.1148/radiol.247107061118372465
    [Google Scholar]
  11. RamalhoM. HerédiaV. CardosoC. MatosA.P. PalasJ. De FreitasJ. SemelkaR.C. Magnetic resonance imaging of small bowel Crohn’s disease.Acta Med. Port.201225423124010.20344/amp.6223079251
    [Google Scholar]
  12. GourtsoyiannisN.C. GrammatikakisJ. PapamastorakisG. KoutroumbakisJ. PrassopoulosP. RousomoustakakiM. PapanikolaouN. Imaging of small intestinal Crohn’s disease: Comparison between MR enteroclysis and conventional enteroclysis.Eur. Radiol.20061691915192510.1007/s00330‑006‑0248‑816673093
    [Google Scholar]
  13. ChoiJ.Y. KimM.J. ChungY.E. KimJ.Y. JonesA.C. de BeckerJ. van CauterenM. Abdominal applications of 3.0-T MR imaging: Comparative review versus a 1.5-T system.Radiographics2008284e3010.1148/rg.e3018426969
    [Google Scholar]
  14. Saeid SeyedianS. NokhostinF. Dargahi MalamirM. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.J. Med. Life201912211312210.25122/jml‑2018‑007531406511
    [Google Scholar]
  15. AksanA. FarragK. BlumensteinI. SchröderO. DignassA.U. SteinJ. Chronic intestinal failure and short bowel syndrome in Crohn’s disease.World J. Gastroenterol.202127243440346510.3748/wjg.v27.i24.344034239262
    [Google Scholar]
  16. De CruzP. KammM.A. HamiltonA.L. RitchieK.J. KrejanyE.O. GorelikA. LiewD. PrideauxL. LawranceI.C. AndrewsJ.M. BamptonP.A. GibsonP.R. SparrowM. LeongR.W. FlorinT.H. GearryR.B. Radford-SmithG. MacraeF.A. DebinskiH. SelbyW. KronborgI. JohnstonM.J. WoodsR. ElliottP.R. BellS.J. BrownS.J. ConnellW.R. DesmondP.V. Crohn’s disease management after intestinal resection: A randomised trial.Lancet201538599761406141710.1016/S0140‑6736(14)61908‑525542620
    [Google Scholar]
  17. GeylS. GuilloL. LaurentV. D’AmicoF. DaneseS. Peyrin-BirouletL. Transmural healing as a therapeutic goal in Crohn’s disease: A systematic review.Lancet Gastroenterol. Hepatol.20216865966710.1016/S2468‑1253(21)00096‑034090579
    [Google Scholar]
  18. AlyamiA. HoadC.L. TenchC. BannurU. ClarkeC. LatiefK. ArgyriouK. LoboA. LungP. Baldwin-ClelandR. SahnanK. HartA. LimdiJ.K. MclaughlinJ. AtkinsonD. ParkerG.J.M. O’ConnorJ.P.B. LittleR.A. GowlandP.A. MoranG.W. Quantitative magnetic resonance imaging in perianal crohn’s disease at 1.5 and 3.0 T: A feasibility study.Diagnostics20211111213510.3390/diagnostics1111213534829482
    [Google Scholar]
  19. LeeS. ChoiY.H. ChoY.J. CheonJ.E. MoonJ.S. KangG.H. KimW.S. Quantitative evaluation of Crohn’s disease using dynamic contrast-enhanced MRI in children and young adults.Eur. Radiol.20203063168317710.1007/s00330‑020‑06684‑132078012
    [Google Scholar]
  20. WardM.G. KariyawasamV.C. MoganS.B. PatelK.V. PantelidouM. Sobczyńska-MaleforaA. PortéF. GriffinN. AndersonS.H.C. SandersonJ.D. HarringtonD.J. IrvingP.M. Prevalence and risk factors for functional vitamin B12 deficiency in patients with Crohnʼs Disease.Inflamm. Bowel Dis.201521122839284710.1097/MIB.000000000000055926296064
    [Google Scholar]
  21. JiangX. AsbachP. HammB. XuK. BanzerJ. MR imaging of distal ileal and colorectal chronic inflammatory bowel disease—diagnostic accuracy of 1.5 T and 3 T MRI compared to colonoscopy.Int. J. Colorectal Dis.201429121541155010.1007/s00384‑014‑2037‑125339134
    [Google Scholar]
  22. Abd-El Khalek Abd-ALRazekA. FahmyD.M. Diagnostic value of diffusion-weighted imaging and apparent diffusion coefficient in assessment of the activity of Crohn Disease: 1.5 or 3 T.J. Comput. Assist. Tomogr.201842568869610.1097/RCT.000000000000075429958199
    [Google Scholar]
  23. van Gemert-HorsthuisK. FlorieJ. HommesD.W. Lavini MPhilC. ReitsmaJ.B. van DeventerS.J. StokerJ. Feasibility of evaluating Crohn’s disease activity at 3.0 Tesla.J. Magn. Reson. Imaging200624234034810.1002/jmri.2065016786589
    [Google Scholar]
  24. FiorinoG. BonifacioC. PadrenostroM. SpostaF.M. SpinelliA. MalesciA. BalzariniL. Peyrin-BirouletL. DaneseS. Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn’s disease.Dig. Dis. Sci.201358113246325510.1007/s10620‑013‑2781‑z23903867
    [Google Scholar]
  25. SinhaR. MurphyP. SandersS. RamachandranI. HawkerP. RawatS. RobertsS. Diagnostic accuracy of high-resolution MR enterography in Crohn’s disease: Comparison with surgical and pathological specimen.Clin. Radiol.201368991792710.1016/j.crad.2013.02.01223622798
    [Google Scholar]
  26. FletcherJ.G. FidlerJ.L. BruiningD.H. HuprichJ.E. New concepts in intestinal imaging for inflammatory bowel diseases.Gastroenterology2011140617951806.e710.1053/j.gastro.2011.02.01321530746
    [Google Scholar]
  27. YuY.R. RodriguezJ.R. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.Semin. Pediatr. Surg.201726634935510.1053/j.sempedsurg.2017.10.00329126502
    [Google Scholar]
  28. LoftusE.V.Jr Crohn’s Disease: Etiology, complications, assessment, therapy, and management.Gastroenterol. Clin. North Am.2017463xiiixv10.1016/j.gtc.2017.06.00128838422
    [Google Scholar]
  29. LaassM.W. RoggenbuckD. ConradK. Diagnosis and classification of Crohn’s disease.Autoimmun. Rev.2014134-546747110.1016/j.autrev.2014.01.02924424189
    [Google Scholar]
  30. GilesE. BarclayA.R. ChippingtonS. WilsonD.C. Systematic review: MRI enterography for assessment of small bowel involvement in paediatric Crohn’s disease.Aliment. Pharmacol. Ther.201337121121113110.1111/apt.1232323638954
    [Google Scholar]
  31. SchreyerA.G. GölderS. ScheiblK. VölkM. LenhartM. TimmerA. SchölmerichJ. FeuerbachS. RoglerG. HerfarthH. SeitzJ. Dark lumen magnetic resonance enteroclysis in combination with MRI colonography for whole bowel assessment in patients with Crohn’s disease: first clinical experience.Inflamm. Bowel Dis.200511438839410.1097/01.MIB.0000164022.72729.0615803030
    [Google Scholar]
  32. SinhaR. VermaR. VermaS. RajeshA. MR enterography of Crohn disease: Part 1, rationale, technique, and pitfalls.AJR Am. J. Roentgenol.20111971767910.2214/AJR.10.725321701013
    [Google Scholar]
  33. García-BoschO. OrdásI. AceitunoM. RodríguezS. RamírezA.M. GallegoM. RicartE. RimolaJ. PanesJ. Comparison of diagnostic accuracy and impact of magnetic resonance imaging and colonoscopy for the management of Crohn’s Disease.J. Crohn’s Colitis201610666366910.1093/ecco‑jcc/jjw01526783346
    [Google Scholar]
  34. Jauregui-AmezagaA. RimolaJ. OrdásI. RodríguezS. Ramírez-MorrosA. GallegoM. MasamuntM.C. LlachJ. González-SuárezB. RicartE. PanésJ. Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn’s disease in the era of biologics.Gut20156491397140210.1136/gutjnl‑2014‑30810125516418
    [Google Scholar]
/content/journals/cmir/10.2174/0115734056267653231129104404
Loading
/content/journals/cmir/10.2174/0115734056267653231129104404
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test